Patent: 10,307,482
✉ Email this page to a colleague
Summary for Patent: 10,307,482
Title: | Nanoparticle complexes of paclitaxel, cetuximab, and albumin |
Abstract: | Described are nanoparticle complexes comprising paclitaxel, albumin and anti-EGFR antibodies. The nanoparticle complexes are suitable for the treatment of cancer, in particular cancer that expresses EGFR. |
Inventor(s): | Markovic; Svetomir N. (Rohester, MN), Nevala; Wendy K. (Rohester, MN) |
Assignee: | Mayo Foundation for Medical Education and Research (Rochester, MN) |
Application Number: | 15/412,564 |
Patent Claims: | see list of patent claims |
Details for Patent 10,307,482
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2032-10-01 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2032-10-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |